Fissios© and Postoperative Complications (FPoC Trial)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCarlos Alfredo Fraile Olivero, MD, PhD.

About this trial

Respiratory physiotherapy as part of a pre-operative physical training program may reduce the risk of developing post-operative complications, improving post-operative results and optimizing physical conditions in patients with a diagnosis of non-small cell lung cancer (NSCLC) undergoing lung resection surgery. During the post-operative period, performing physical exercise has also been proved to increase the capacity for exercise, improve health-related quality of life and reduce the feeling of breathlessness. Fissios App is a tool created by thoracic surgeons, physiotherapists and a specialist doctor in physical medicine and rehabilitation, which has been satisfactorily implemented in thoracic surgery patients; this contains a program of standardized respiratory physiotherapy exercises with a defined time and number of repetitions.

The aim is to compare the effectiveness of use of the Fissios App tool as a complement to a peri-operative respiratory physiotherapy program compared to just attendance at a face-to-face peri-operative respiratory physiotherapy program, to reduce the incidence of post-operative complications.

It is expected to include 560 patients in the study. Subsequent to evaluation by the investigator and the acceptance of participant to take part in the study, the performing of peri-operative respiratory physiotherapy is prescribed. The participants will be randomly assigned to a study group that uses the tool as a complement to the respiratory physiotherapy program or a control group that should only attend face-to-face respiratory physiotherapy sessions. All the participants should attend face-to-face respiratory physiotherapy classes taught by physiotherapists at the place and time set out in each centre before and after surgery for at least 45 minutes and at least five sessions. Moreover, study group participants may use the Fissios App tool. Investigators should fill in the pre-operative, surgery and post-operative data for each patient on the Fissios Research platform.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients over 18 years of age.

Indication for lung resection surgery due to diagnostic suspicion or histopathological diagnosis of non-small cell lung carcinoma.

Anatomical lung resection surgery: anatomical segmental resection, lobectomies or pneumonectomies, using a conventional or minimally invasive approach (VATS, RATS).

The patient has a smart mobile device compatible with the Fissios App©, has the ability or has the support to use it.

Disqualifiers

Medical contraindication to perform respiratory physiotherapy exercises.

Not possessing a smart mobile device compatible with Fissios App©.

Inability of the patient to perform the exercises, either due to a physical or psychological impediment.

Inability to complete the informed consent form for participation in the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • On-site respiratory physiotherapy

    Procedure/Surgery

    The patient attends face-to-face physiotherapy sessions prescribed by the doctor.

  • Fissios App

    Device

    The patient uses the Fissios App to perform respiratory physiotherapy exercises.

Treatment groups

560 Participants
are divided into 2 treatment groups
Group A: In-person respiratory physiotherapyActive comparator 1 intervention
Group B: Face-to-face respiratory physiotherapy plus use of the Fissios AppExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Postoperative complications

Development of at least one adverse clinical event categorised as a postoperative complication during hospital admission. Immediately after the surgery until discharge.

Time frame
Through postoperative evolution, an average of 2 weeks.

Secondary outcomes

1

Duration of pleural drainage

Time that the patient has pleural drainage from the end of surgery until medical discharge.

Time frame
Through postoperative evolution, an average of 2 weeks.
2

Mortality

Patient status at the moment of discharge.

Time frame
During hospitalization period, an average of 2 weeks.
3

Hospital readmission

Any clinical situation requiring hospital admission

Time frame
Within 30 days of discharge from hospital
4

Mortality

Time frame
During the first 30 days after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Carlos Alfredo Fraile Olivero, MD, PhD.

Lead sponsor

Hospital San Carlos, Madrid

Sponsor institution

Spanish Society of Pneumology and Thoracic Surgery (SEPAR)

Collaborator

Asociación Española de Afectados de Cáncer de Pulmón (AEACaP)

Collaborator

Medtronic General Research Grant

Collaborator

Spanish Society of Thoracic Surgery (SECT)

Collaborator